SOURCE: CDEX Inc.

CDEX Inc.

January 27, 2011 08:30 ET

CDEX Ships First Order of Pocket ID2 Device to Lifeloc Technologies

TUCSON, AZ--(Marketwire - January 27, 2011) - CDEX (OTCBB: CEXI) (www.cdexinc.com), a leading developer of chemical detection products, using patented technologies, for use in healthcare and security markets, announced today the initial shipment of its new Pocket ID2 Scanner to Lifeloc Technologies. The Pocket ID2 Scanner detects the illegal drug Methamphetamine (Meth). Studies by the National Survey on Drug Use and Health have estimated Crystal Meth addiction is now the largest illegal drug pandemic gripping the nation. Lifeloc Technologies is a leading supplier of breath alcohol testers for domestic and international law enforcement, corrections, and workplace testing.

"Management is pleased to announce this shipment of our best in class illegal substance detectors to an industry leader such as Lifeloc," said Jeff Brumfield, CEO and Chairman of the Board of CDEX Inc. "We believe that our Pocket ID2 is an ideal tool for combating the multibillion dollar international methamphetamine epidemic. Lifeloc Technologies' vast market presence and sterling industry reputation coupled with CDEX's expansive intellectual property catalog provide countless opportunities for future growth. We are confident that this partnership will provide CDEX Inc. access to key law enforcement agencies and additional sales opportunities around the world. Going forward, we will remain focused on expanding market presence, improving financial metrics and increasing overall shareholder value."

The Pocket ID2 allows law enforcement officers and other agencies to carry and conceal the device easily. The Pocket ID2 was developed with the Company's patented technologies that detect and verify the presence of meth at the visible and prosecutable range. Test results are instantaneous and non-destructive and can be conducted without touching or disturbing the surfaces scanned, thus minimizing officer exposure and preserving the integrity of the sample. The innovative technology is designed for use in law enforcement, correctional facilities and other applications where definitive and immediate results are necessary.

A recent report by the RAND Corporation in 2005 titled 'The Economic Cost of Methamphetamine Use in the United States' estimated the cost of meth abuse at $23.4 billion annually in the US, imposing serious costs to the criminal justice system. The results of a survey conducted in 2007 by the National Association of Counties reported by law enforcement officials from 45 states showed that Meth is still the number one drug problem agencies deal with.

About Lifeloc Technologies
For more than 25 years Lifeloc Technologies, Inc. has served the law enforcement, corrections and workplace communities as a leading global designer and manufacturer of professional breath alcohol testers. More than 35 countries currently utilize Lifeloc's breath alcohol testing equipment for workplace, DOT, law enforcement, education and corrections testing. Lifeloc products, proudly manufactured and serviced in the USA, are recognized worldwide for their ease-of-use, accuracy and reliability. To learn more about Lifeloc and the Pocket ID2 Scanner please visit www.lifeloc.com.

About CDEX
CDEX develops, manufactures and globally distributes products to the healthcare and security markets. The ValiMed product line provides life-saving validation of high-risk medications and returned narcotics. The ID2™ product line detects trace amounts of illegal drugs, such as methamphetamine. CDEX expects to advance its patented technologies to serve additional markets in the future where its proprietary products can be launched. To learn more about CDEX please visit www.cdex-inc.com.

Safe Harbor Statement
Non-historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as "expects," "plans," "may," "believes," "should," "intends," and similar words. These statements pose risks that cannot be accurately predicted. Consequently, results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the protection of intellectual property and proprietary information, and other risks detailed periodically in filings with the SEC. There is no obligation to update any forward-looking statements.

Contact Information